ISOPRIKA isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
11-04-2022

유효 성분:

isoprenaline hydrochloride, Quantity: 200 microgram

제공처:

Micro Labs Pty Ltd

약제 형태:

Injection, solution

구성:

Excipient Ingredients: citric acid; hydrochloric acid; sodium chloride; sodium citrate dihydrate; disodium edetate; sodium hydroxide; water for injections

관리 경로:

Intracardial, Intramuscular, Intravenous Bolus, Intravenous Infusion, Subcutaneous

패키지 단위:

25 x 1 mL ampoules, 5 x 1 mL ampoules

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Isoprenaline Hydrochloride is indicated: For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,For serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation). (See Section 4.3 Contraindications),For use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (See Section 4.3 Contraindications.),For bronchospasm occurring during anaesthesia.,As an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (See Section 4.4 Special warnings and precautions for use).

제품 요약:

Visual Identification: Clear, colorless to slightly yellow colour solution. Practically free from any visible particles.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Registered

승인 날짜:

2022-02-10